Financial Sense Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Financial Sense Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-64,641	Closed	-$6.13M	–	136
2024 Q1	$6.13M	Buy	+64,641	New	+$6M	2.02%	13
2022 Q4	–	Sell	-4,146	Closed	-$329K	–	105
2022 Q3	$329K	Sell	4,146 -139	-3%	-$11.7K	0.14%	67
2022 Q2	$318K	Sell	4,285 -805	-16%	-$60.4K	0.12%	81
2022 Q1	$457K	Buy	5,090 +531	+12%	+$49K	0.17%	45
2021 Q4	$510K	Sell	4,559 -3	-0.1%	-$362	0.18%	71
2021 Q3	$574K	Sell	4,562 -131	-3%	-$16.9K	0.19%	70
2021 Q2	$635K	Sell	4,693 -541	-10%	-$71.1K	0.2%	70
2021 Q1	$710K	Sell	5,234 -755	-13%	-$113K	0.24%	67
2020 Q4	$843K	Sell	5,989 -3,926	-40%	-$503K	0.31%	55
2020 Q3	$1.1M	Buy	9,915 +3,506	+55%	+$393K	0.44%	42
2020 Q2	$718K	Buy	6,409 +2,290	+56%	+$226K	0.26%	51
2020 Q1	$319K	Sell	4,119 -161	-4%	-$14.3K	0.14%	73
2019 Q4	$407K	Buy	4,280 +255	+6%	+$22.1K	0.15%	62
2019 Q3	$307K	Hold	4,025	–	–	0.15%	59
2019 Q2	$353K	Buy	4,025 +1,270	+46%	+$108K	0.16%	52
2019 Q1	$249K	Buy	+2,755	New	+$234K	0.11%	52
2018 Q4	–	Sell	-4,152	Closed	-$398K	–	73
2018 Q3	$398K	Buy	4,152 +838	+25%	+$81.2K	0.17%	53
2018 Q2	$315K	Buy	3,314 +151	+5%	+$13.9K	0.22%	47
2018 Q1	$277K	Buy	3,163 +1	+0%	+$91	0.13%	64
2017 Q4	$268K	Buy	3,162 +59	+2%	+$4.94K	0.12%	63
2017 Q3	$269K	Buy	+3,103	New	+$249K	0.14%	60

Other funds holding XBI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Financial Sense Advisors's XBI Position: Q2 2024 in Review

Financial Sense Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 64,641 shares — an estimated $6.13M sold.

Financial Sense Advisors first reported a position in XBI in Q3 2017 and held it in 21 quarters. The position peaked at $6.13M in Q1 2024. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Financial Sense Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
Financial Sense Advisors sold 64,641 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $6.13M.
Financial Sense Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and held it in 21 quarters.
Financial Sense Advisors's State Street SPDR S&P Biotech ETF position peaked at $6.13M in Q1 2024.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Financial Sense Advisors's 13F filing for Q2 2024, filed 24 Jul 2024.